Logo
🚀 Pharmidex Unveils Its Cutting-Edge In Silico Drug Discovery Platform! 🧬💻
February 24, 2025

At Pharmidex, we are revolutionizing drug discovery with our state-of-the-art in silico platform (https://lnkd.in/eibfwguP), accelerating the path from target identification to lead optimization with precision and efficiency.

🔬 What sets our platform apart?
✅ AI-driven target identification & protein structure analysis
✅ Advanced molecular docking for high-affinity ligand screening
✅ 3D pharmacophore modeling for enhanced drug design
✅ Seamless integration of predictive simulations & real-world validation

Our approach combines cutting-edge computational tools with deep scientific expertise to de-risk drug development and fast-track novel therapeutics for a healthier future.

📽️ Watch our latest video(1/5) showcasing the power of our technology, starting from Determination of target structures and Determination of ligands

📩 Ready to transform your drug discovery journey? Let’s collaborate!

February 26, 2025
Pharmidex continues advancing computational drug discovery! After identifying active/binding sites, our Molecular Docking step ensures precise interaction analysis between potential drug candidates and target proteins, streamlining lead optimization. ✨ Why is this step key? ✅ Predicts binding affinity and stability of drug candidates ✅ AI-enhanced docking for high-precision molecular interactions ✅ Accelerates hit-to-lead identification with accurate simulations ✅ Seamlessly integrates with the next in silico pipeline steps By combining cutting-edge modeling and expert-driven analysis, we de-risk drug development and fast-track novel therapeutic discoveries. 📽️ Watch our latest video (3/5) showcasing how we refine drug-target interactions through Molecular Docking! 📩 Let’s collaborate to transform drug discovery! #DrugDiscovery #Pharmidex #AIinBiotech #MolecularDocking #PharmaceuticalInnovation
OBN BioTuesday
February 25, 2025
OBN BioTuesday
February 25, 2025
At Pharmidex , we continue to push the boundaries of computational drug discovery! Following target structure and ligand determination, our advanced Determination of Active/Binding Sites step ensures precise identification of key molecular interactions, optimizing drug design for success. ✨ Why is this step crucial? ✅ Accurate identification of binding pockets for targeted drug interactions ✅ AI-powered pocket detection and molecular dynamics simulations ✅ Enhanced precision in hit identification and lead optimization ✅ Seamless integration with our next in silico pipeline steps By leveraging cutting-edge computational tools, we de-risk drug development and accelerate therapeutic innovation. Stay tuned for the next stage in our in silico pipeline! 📽️ Watch our latest video (2/5) to explore how we map active sites with precision! 📩 Let’s collaborate to revolutionize drug discovery! #DrugDiscovery #Pharmidex #AIinBiotech #MolecularModeling #PharmaceuticalInnovation
More Posts
Share by: